Madison, Wis. ââ?¬â? Massachusetts-based Genzyme Corp. said on Wednesday it has agreed to buy Bone Care International, a University of Wisconsin-Madison biotech spinoff, for $600 million in cash.
Office of Strategic Communication
Madison, Wis. ââ?¬â? Massachusetts-based Genzyme Corp. said on Wednesday it has agreed to buy Bone Care International, a University of Wisconsin-Madison biotech spinoff, for $600 million in cash.